Newtown, PA – According to filings with the U.S. Securities and Exchange Commission, Helius Medical Technologies is raising $3,420,664.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Joyce Laviscount played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Helius Medical Technologies

At Helius Medical Technologies, we’re using the power of our collective curiosity, talent, and experience to change the lives of those affected by neurologic diseases such as traumatic brain injury, multiple sclerosis, stroke, and cerebral palsy. We know how symptoms of these brain disorders can marginalize those affected and we’re committed to changing that dynamic through the development of new neurotech treatments that will reset both the standards and expectations of care. Our first innovation is the Portable Neuromodulation Stimulator, or PoNS, an investigational, non-invasive therapy that combines stimulation of the trigeminal nerve through the tongue with focused rehabilitation to unlock the brain’s ability to restore lost function.

To learn more about Helius Medical Technologies, visit http://www.heliusmedical.com/

Contact:
Joyce Laviscount, Chief Financial Officer
215-944-6100
https://www.linkedin.com/in/joyce-laviscount-5504b81/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved